DraftKings’ bulls were thrown an unexpected curveball, but this new competition doesn’t carry the same brand-name cache. After years of development, Recursion Pharmaceuticals’ AI-powered drug discovery technology should finally, firmly start proving its true value.
Source: https://www.fool.com/investing/2026/01/29/forget-2025-these-…
